logo

For the Inventor, By the Inventor

Corpus Christi, TX, United States of America

Robert P Barnes

This inventor holds 3 USPTO granted patents. Top assignees: The University of Texas System, Other. Active years: 1986-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert P Barnes. Retrieved from https://idiyas.com/inventor/robert-p-barnes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 33.3

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Corpus Christi, TX (US) (1986)
  • Frisco, TX (US) (2002 - 2004)

Company Filing History:

goldMedal1 out of 5,649 
 
The University of Texas System
 patents
silverMedal2 out of 834,708 
Other
 patents

Years Active: 1986-2004

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6821750 - ABCG8 vectors, host cells, and method of making (2004-11-23),
2. 6465196 - Drug screen for identifying an agent that modulates low density lipoprotein receptor adaptin-ligand binding (2002-10-15),
3. 4586572 - Well drilling apparatus (1986-05-06),

Title: The Innovations of Robert P Barnes

Introduction

Robert P Barnes is a notable inventor based in Corpus Christi, TX (US). He has made significant contributions to the field of cholesterol regulation through his innovative patents. With a total of 3 patents, his work has implications for the diagnosis and treatment of cholesterol-associated disorders.

Latest Patents

Barnes' latest patents include groundbreaking inventions such as ABCG8 vectors, host cells, and methods of making. The first patent provides nucleic acids encoding a novel ABC family cholesterol transporter, ABCG8. These sequences can be utilized for various purposes, including diagnosing and treating cholesterol-related disorders like sitosterolemia. His second patent focuses on drug screening for identifying agents that modulate low-density lipoprotein receptor adaptin-ligand binding. This invention highlights the role of low-density lipoprotein receptor (LDLR) adaptin as a key component in human cholesterol regulation, offering a target for drug design and therapeutic intervention.

Career Highlights

Throughout his career, Robert P Barnes has worked with esteemed institutions, including the University of Texas System. His innovative research has positioned him as a key figure in the field of cholesterol regulation and drug design.

Collaborations

Barnes has collaborated with notable individuals such as Helen H Hobbs and Thomas A Myers, further enhancing the impact of his work in the scientific community.

Conclusion

Robert P Barnes continues to be a significant contributor to the field of cholesterol research through his innovative patents and collaborations. His work not only advances scientific understanding but also holds promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…